Nasdaq Marketsmarketsinvestment opinion
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case. (opens at Nasdaq Markets in a new tab)
Viking Therapeutics trades well below Wall Street price targets. The article presents the skeptics' case against the stock.
